Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 9204894.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Highly active antiretroviral therapy (HAART) increases CD4(+) cell numbers, but its ability to correct the human immunodeficiency virus (HIV)-induced immune deficiency remains unknown. A three-phase T cell reconstitution was demonstrated after HAART, with: (i) an early rise of memory CD4(+) cells, (ii) a reduction in T cell activation correlated to the decreasing retroviral activity together with an improved CD4(+) T cell reactivity to recall antigens, and (iii) a late rise of "naïve" CD4(+) lymphocytes while CD8(+) T cells declined, however, without complete normalization of these parameters. Thus, decreasing the HIV load can reverse HIV-driven activation and CD4(+) T cell defects in advanced HIV-infected patients.
Medical subject headings
- Anti-HIV Agents
- CD4-Positive T-Lymphocytes
- HIV Infections
- HIV-1
- T-Lymphocyte Subsets